MedPath

A Comparative Study of Sibling Oocytes: ICSI vs. the PICSI Sperm Selection Method

Not Applicable
Conditions
Infertility
Registration Number
NCT03240302
Lead Sponsor
Hillel Yaffe Medical Center
Brief Summary

The aim of this research is to compare sibling oocytes using two sperm selection methods for choosing the best quality spermatozoa before they are injected into oocytes and the influence of each of these methods on embryo quality and IVF outcome.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Males aged 18-60
  • Females aged 18-35
  • Males with mild OTA (oligo terato astheno zoospermia) and at least one failed IVF cycle
  • Males with normozoospermia with at least 2 unexplained failed IVF cycles
  • Females with normal FSH and normal AMH values
  • Females who have retrieved in previous cycles at least 6 oocytes
Exclusion Criteria
  • Couples who have been exposed to heavy smoking, drugs and chronic diseases
  • Males who have undergone testicular surgery (TESE) or defined as severe OTA
  • Females with egg factor infertility

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Comparison of fertilization rateThree years

Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The fertilization rates of the ICSI and PICSI methods will be compared.

Comparison of embryo qualityThree years

Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The embryo quality of the ICSI and PICSI methods will be compared.

Secondary Outcome Measures
NameTimeMethod
Live birth rateThree years

Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The live birth rates of the ICSI and PICSI methods will be compared.

Implantation rateThree years

Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The implantation rates of the ICSI and PICSI methods will be compared.

Pregnancy rateThree years

Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The pregnancy rates of the ICSI and PICSI methods will be compared.

Miscarriage rateThree years

Injected sibling oocytes are incubated in a time-lapse incubator which enables ongoing observation after fertilization and cleavage of each oocyte. The miscarriage rates of the ICSI and PICSI methods will be compared.

Trial Locations

Locations (1)

Hillel Yaffe Medical Center

🇮🇱

Hadera, Israel

Hillel Yaffe Medical Center
🇮🇱Hadera, Israel
Medeia Michaeli, PhD
Contact
972-50-6246885
medeia.michaeli@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.